Marc Longpre

 
 

Recent Articles

ImpediMed taps Russo for surgeon education campaign

March 26, 2008

NEW YORK: ImpediMed, the Australian medical device company, has named Russo Partners as its US agency in order to support a campaign geared at educating breast surgeons on the "lymphedema index."

In the spotlight

March 24, 2008

Partnering with a big pharma entity can be a tremendous coup for a biotech company, but it also presents a number of challenges on the comms front.

FDA forthcoming on heparin investigation

March 21, 2008

The Food and Drug Administration's (FDA) announcement that the toxin in heparin is over-sulfated chondroitin sulfate demonstrated unusual efficiency by the agency

BIO IT Coalition enlists WE for support

March 18, 2008

WASHINGTON: The BIO IT Coalition, a Washington-based nonprofit serving the bridge between the life sciences and information technology industries, has chose Waggener Edstrom to provide PR support to the organization.

Southwest CEO apologizes to consumers

March 14, 2008

Southwest Airlines CEO Gary Kelly apologized to customers and safety regulators this morning in an interview with The Wall Street Journal, likely signaling the beginning of a communications effort to repair the company's image with consumers and other stakeholders.

5W sues its former HR head

March 13, 2008

NEW YORK: 5W Public Relations has filed suit against Melissa Weiss, the firm's former human resources director, for allegedly soliciting employees for positions with other agencies.

IPG, WPP Group grow in '07

March 06, 2008

NEW YORK, LONDON: Holding companies Interpublic Group (IPG) and WPP Group both posted healthy earnings growth in 2007.

KKI gets Americans tuned into autism

March 03, 2008

Through podcasts and news shows, Kennedy Krieger and Spectrum spread autism awareness

Spreading the truth

March 03, 2008

The American Legacy Foundation uses a variety of creative tactics in its quest to reach teens with a message about the dangers of smoking. Marc Longpre reports

WS helps Genentech with FDA approval of new drug

February 29, 2008

WASHINGTON, DC: Weber Shandwick aided Genentech on communications work leading to approval from the Food and Drug Administration (FDA) of Avastin, a drug used in treating metastatic breast cancer, sources told PRWeek.
 
Home | News | Newsletters | Blogs | Directory | PR Jobs | Events | Subscribe | Issue Archive | Contact Us | About Us | Editorial Calendar | Reprints | Advertising | Subscribe to our RSS feeds RSS

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions